|
시장보고서
상품코드
2008154
Suboxone 시장 : 유형별, 제형별, 유통 채널별, 지역별Suboxone Market, By Type, By Formulation, By Distribution Channel, By Geography |
||||||
Suboxone 시장은 2026년에 74억 달러로 추정되고 있으며, 2033년까지 96억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 4.1%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 74억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2026-2033년) | 4.10% | 예측 금액(2033년) | 96억 달러 |
서브옥손은 진통 작용 등 오피오이드 중독을 유발할 수 있는 오피오이드 계열 의약품의 효과를 억제하기 위해 사용되는 처방약입니다. 서브옥손은 오피오이드 중독 치료에 단독으로 또는 다른 약물과 병용하여 사용할 수 있습니다. 서브옥손은 오피오이드 길항제, 진통제, 오피오이드 부분 작용제로 알려진 약물 분류에 속합니다. 서브옥손은 부프레노르핀과 날록손으로 구성되어 있습니다. 부프레노르핀은 오피오이드 계열의 약물로 마약이라고 불리기도 합니다. 날록손은 진통, 행복감 등 오피오이드 계열 약물의 작용을 상쇄시켜 오피오이드 의존성을 예방하는 역할을 합니다.
시장 역학
서브옥손의 신제품 출시 증가는 예측 기간 중 글로벌 서브옥손 시장의 성장을 촉진할 것으로 예상됩니다. 2018년 9월, 글로벌 제약사 Lannett Co Inc.는 부프레노르핀+날록손 설하정 등 5가지 제품을 출시했습니다.
또한 특정 지역의 오피오이드 처방 증가는 예측 기간 중 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어 새로운 오픈 액세스 임상 저널인 Eclinical Medicine이 2021년 11월에 발표한 연구에 따르면 전 세계에서 처방률이 감소하고 있음에도 불구하고 영국은 통증 관리를 위한 처방용 오피오이드의 1인당 소비율이 세계에서 가장 높은 것으로 나타났습니다.
또한 만성 통증의 유병률 증가는 예측 기간 중 글로벌 서브옥손 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 미국 질병예방통제센터(CDC)가 2018년 9월 발표한 자료에 따르면 2016년 기준 미국 성인의 약 20.4%(5,000만 명)가 만성통증을 앓고 있으며, 8.0%(1,960만 명)가 생활에 큰 영향을 미치는 만성통증을 앓고 있으며, 그 유병률은 연령이 높아질수록 증가하는 것으로 나타났습니다. 유병률은 고령화와 함께 높아지는 것으로 나타났습니다.
이 보고서의 주요 특징
- 세계의 서브옥손(Suboxone) 시장에 대해 조사 분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모와 CAGR을 조사 분석하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 세계의 서브옥손 시장의 주요 기업 개요을 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계의 서브옥손 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 서브옥손 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 Suboxone 시장 : 유형별(2026-2033년)
제5장 세계의 Suboxone 시장 : 제형별(2026-2033년)
제6장 세계의 Suboxone 시장 : 유통 채널별(2026-2033년)
제7장 세계의 Suboxone 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 섹션
KSA 26.05.04Suboxone Market is estimated to be valued at USD 7.4 Bn in 2026 and is expected to reach USD 9.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.4 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.10% | 2033 Value Projection: | USD 9.6 Bn |
Suboxone is a prescription opioid medication that is used to inhibit the effects of opioid medications, such as pain relief, which can lead to opioid dependence. Suboxone can be used alone or in combination with other drugs to treat opioid addiction. Suboxone belongs to a drug class known as opioid antagonists, analgesics, and opioid partial agonists. Suboxone is composed of buprenorphine and naloxone. Buprenorphine is an opioid medicine, sometimes known as a narcotic. Naloxone counteracts the benefits of opioid medications, such as pain relief and feelings of well-being, which can lead to opioid dependence.
Market Dynamics
The increasing product launches for suboxone is expected to drive the growth of global suboxone market over the forecast period. In September 2018, Lannett Co Inc., a global manufacturer of pharmaceutical products, launched five products that include Buprenorphine plus Naloxone Sublingual tablets, and others.
Moreover, increasing prescription of opioids in certain regions is expected to drive the market growth over the forecast period. For instance, a research published by EclinicalMedicine, a new open access clinical journal, in November 2021 stated that the U.K. had the highest consumption rate of prescription opioids for pain management per capita in the world, despite declining rates globally.
Furthermore, increasing prevalence of chronic pain is expected to drive the growth of global suboxone market over the forecast period. For instance, according to data published by Centers for Disease Control and Prevention in September 2018, stated that an estimated 20.4% of the U.S. adults (50.0 million) had chronic pain and 8.0% of the U.S. adults (19.6 million) had high-impact chronic pain with higher prevalence associated with advancing age in 2016.
Key features of the study
- This report provides an in-depth analysis of the global suboxone market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global suboxone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Indivior PLC, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Rhodes Pharmaceuticals L.P., Alvogen, Sun Pharmaceutical Industries Ltd., Alkem Labs, and Hikma Pharmaceuticals PLC
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global suboxone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global suboxone market
Market Segmentation
- By Type
- Branded
- Generics
- By Formulation
- Tablets
- Films
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Indivior PLC
- Reddy's Laboratories Ltd.
- Amneal Pharmaceuticals LLC.
- Mylan N.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt
- Lannett Co Inc.
- Rhodes Pharmaceuticals L.P.
- Alvogen
- Sun Pharmaceutical Industries Ltd.
- Alkem Labs
- Hikma Pharmaceuticals PLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Formulation
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- New Product Launches
- Regulatory Scenario
- PEST Analysis
- PORTER's Analysis
- Key Developments
- Brand Analysis
- Strategic Agreement, Merger And Acquisitions
4. Global Suboxone Market, By Type, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Branded
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Generics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Suboxone Market, By Formulation, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Tablets
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Films
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Suboxone Market, By Distribution Channel, 2026 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Suboxone Market, By Region, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Indivior PLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy's Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amneal Pharmaceuticals LLC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mallinckrodt
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Lannett Co Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rhodes Pharmaceuticals L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alvogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alkem Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
